| Arsenic trioxide-mediated cytotoxicity and apoptosis in prostate and ovarian carcinoma cell lines R Uslu, UA Sanli, C Sezgin, B Karabulut, E Terzioglu, SB Omay, E Goker Clinical Cancer Research 6 (12), 4957-4964, 2000 | 263 | 2000 |
| Does enalapril prevent peritoneal fibrosis induced by hypertonic (3.86%) peritoneal dialysis solution? S Duman, AI Günal, S Sen, G Asçi, M Özkahya, E Terzioglu, F Akçiçek, ... Peritoneal Dialysis International 21 (2), 219-225, 2001 | 118 | 2001 |
| Cardiac autonomic profile in rheumatoid arthritis and systemic lupus erythematosus M Aydemir, V Yazisiz, I Basarici, AB Avci, F Erbasan, A Belgi, E Terzioglu Lupus 19 (3), 255-261, 2010 | 106 | 2010 |
| Lung involvement in patients with primary Sjögren’s syndrome: what are the predictors? V Yazisiz, G Arslan, İH Ozbudak, S Turker, F Erbasan, AB Avci, ... Rheumatology international 30 (10), 1317-1324, 2010 | 102 | 2010 |
| Cytotoxic and inhibitory effects of 4, 4′-dihydroxy chalcone (RVC-588) on proliferation of human leukemic HL-60 cells G Saydam, HH Aydin, F Sahin, O Kucukoglu, E Erciyas, E Terzioglu, ... Leukemia research 27 (1), 57-64, 2003 | 71 | 2003 |
| Involvement of protein phosphatase 2A in interferon-α-2b-induced apoptosis in K562 human chronic myelogenous leukaemia cells G Saydam, HH Aydin, F Sahin, N Selvi, G Oktem, E Terzioglu, ... Leukemia research 27 (8), 709-717, 2003 | 64 | 2003 |
| Serum tumor growth factor‐β1 levels in patients with cirrhosis, chronic hepatitis B and chronic hepatitis C C Kirmaz, E Terzioglu, O Topalak, P Bayrak, O Yilmaz, G Ersoz, F Sebik European cytokine network 15 (2), 112-116, 2004 | 48 | 2004 |
| Characteristics predicting tuberculosis risk under tumor necrosis factor-α inhibitors: report from a large multicenter cohort with high background prevalence B Kisacik, ON Pamuk, AM Onat, SB Erer, G Hatemi, Y Ozguler, Y Pehlivan, ... The Journal of rheumatology 43 (3), 524-529, 2016 | 46 | 2016 |
| Augmentation of methylprednisolone-induced differentiation of myeloid leukemia cells by serine/threonine protein phosphatase inhibitors S Uzunoglu, R Uslu, M Tobu, G Saydam, E Terzioglu, F Buyukkececi, ... Leukemia research 23 (5), 507-512, 1999 | 46 | 1999 |
| Fundamental principals of tumor necrosis factor-alpha gene therapy approach and implications for patients with lung carcinoma AD Sanlioglu, C Aydin, H Bozcuk, E Terzioglu, S Sanlioglu Lung Cancer 44 (2), 199-211, 2004 | 41 | 2004 |
| Arsenic trioxide and methylprednisolone use different signal transduction pathways in leukemic differentiation S Yuksel, G Saydam, R Uslu, UA Sanli, E Terzioglu, F Buyukececi, ... Leukemia research 26 (4), 391-398, 2002 | 41 | 2002 |
| Concurrent gene therapy strategies effectively destroy synoviocytes of patients with rheumatoid arthritis E Terzioglu, A Bisgin, AD Sanlioglu, M Ulker, V Yazisiz, S Tuzuner, ... Rheumatology 46 (5), 783-789, 2007 | 40 | 2007 |
| T cell subpopulations and IL‐2R in vitiligo K Gunduz, G Ozturk, E Terzioglu, F Sebik The Journal of dermatology 31 (2), 94-97, 2004 | 39 | 2004 |
| Allergy as an etiologic factor in nasal polyposis A Sin, E Terzioglu, A Kokuludag, A Veral, F Sebik, B Karci, T Kabakci Journal of Investigational Allergology and Clinical Immunology 7, 234-237, 1997 | 39 | 1997 |
| CTLA‐4 gene polymorphism of exon 1 (+ 49 A/G) in Turkish systemic lupus erythematosus patients M Ulker, V Yazisiz, N Sallakci, AB Avci, S Sanlioglu, O Yegin, E Terzioglu International journal of immunogenetics 36 (4), 245-250, 2009 | 32 | 2009 |
| Platelet-activating factor and P-selectin activities in thrombotic and nonthrombotic Behçet’s patients SE Tunc, K Aksu, G Keser, F Oksel, E Doganavsargil, T Pirildar, T Turk, ... Rheumatology international 25 (5), 326-331, 2005 | 32 | 2005 |
| Aging and the immune system RM Gorczynski, E Terzioglu International urology and nephrology 40 (4), 1117-1125, 2008 | 31 | 2008 |
| Serum eosinophil cationic protein (ECP) levels in patients with seasonal allergic rhinitis and allergic asthma A Sin, E Terzioglu, A Kokuludag, F Sebik, T Kabakçi Allergy and asthma proceedings 19 (2), 69, 1998 | 29 | 1998 |
| Characterization of the cellular response during apoptosis induction in cadmium-treated Hep G2 human hepatoma cells HH Aydin, HA Celik, R Deveci, E Terzioglu, S Karacali, N Mete, U Akarca, ... Biological trace element research 95 (2), 139-153, 2003 | 26 | 2003 |
| TRAIL Death Receptor-4, Decoy Receptor-1 and Decoy Receptor-2 Expression on CD8+ T Cells Correlate with the Disease Severity in Patients with Rheumatoid … A Bisgin, E Terzioglu, C Aydin, B Yoldas, V Yazisiz, N Balci, H Bagci, ... BMC Musculoskeletal Disorders 11 (1), 192, 2010 | 23 | 2010 |
